John L. Lamattina, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 4,000 shares at $139.79 ($559K) on 2017-11-17, disclosed to the SEC on 2017-11-17.
Seasonal sale ($559k) by Director — this insider has traded LGND in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| LGND | SELL | 2025-11-12 | $1.7M | — | Filing → |
| LGND | SELL | 2024-12-02 | $595K | — | Filing → |
| LGND | SELL | 2021-11-17 | $1.6M | — | Filing → |